Why the study?
Women are more likely to suffer and die from cardiogenic shock complicating acute myocardial infarction, but data regarding their optimal management are scarce.
Does culprit-lesion-only PCI improve outcomes compared to multivessel PCI differently in women versus men with acute myocardial infarction and cardiogenic shock?
Does culprit-lesion-only PCI improve outcomes compared to multivessel PCI differently in women versus men with acute myocardial infarction and cardiogenic shock?
In patients with acute myocardial infarction and cardiogenic shock, sex does not influence the comparative efficacy of culprit-lesion-only versus multivessel PCI.
Answers are grounded in this paper and cite their sources.
Comparable efficacy of culprit-lesion-only versus multivessel PCI across sexes in AMI with shock; confirms no treatment interaction by sex.
BACKGROUND: Women are more likely to suffer and die from cardiogenic shock (CS) as the most severe complication of acute myocardial infarction. Data concerning optimal management for women with CS are scarce. Aim of this study was to better define characteristics of women experiencing CS and to the influence of sex on different treatment strategies. METHODS: In the CULPRIT-SHOCK trial (The Culprit Lesion Only PCI Versus Multivessel PCI in Cardiogenic Shock), patients with CS complicating acute myocardial infarction and multivessel coronary artery disease were randomly assigned to one of the following revascularization strategies: either percutaneous coronary intervention of the culprit-lesion-only or immediate multivessel percutaneous coronary intervention. Primary end point was composite of death from any cause or severe renal failure leading to renal replacement therapy within 30 days. We investigated sex-specific differences in general and according to the revascularization strategies. The primary end point occurred in 56% of women treated by the culprit-lesion-only strategy versus 42% men, whereas 55% of women and 55% of men in the multivessel percutaneous coronary intervention group. CONCLUSIONS: Although women presented with a different risk profile, mortality and renal replacement were similar to men. Sex did not influence mortality and renal failure according to the different coronary revascularization strategies. Based on these data, women and men presenting with CS complicating acute myocardial infarction and multivessel coronary artery disease should not be treated differently. However, further randomized trials powered to address potential sex-specific differences in CS are still necessary. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01927549.
No takes yet. Share an insight, caveat, or question.
Giménez et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: